Related references
Note: Only part of the references are listed.Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
Henna Cederberg et al.
DIABETOLOGIA (2015)
Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms
Pedro Goncalves et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Christoph U. Correll et al.
WORLD PSYCHIATRY (2015)
Risk for Incident Diabetes Mellitus Following Initiation of Second-Generation Antipsychotics Among Medicaid-Enrolled Youths
David M. Rubin et al.
JAMA PEDIATRICS (2015)
Do antipsychotics increase diabetes risk in children and adolescents?
Britta Galling et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Cardiovascular drugs that increase the risk of new-onset diabetes
Kwok Leung Ong et al.
AMERICAN HEART JOURNAL (2014)
Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy
Kang-Ling Wang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
Brandyn D. Henriksbo et al.
DIABETES (2014)
Statin treatment and new-onset diabetes: A review of proposed mechanisms
Marilyne Brault et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Maarten Bak et al.
PLOS ONE (2014)
Risk of type 2 diabetes mellitus associated with statin therapy: evidence and possible mechanisms
Jose Suazo et al.
REVISTA MEDICA DE CHILE (2014)
Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed
Tahireh A. Shams et al.
CURRENT PSYCHIATRY REPORTS (2014)
Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes
Su May Liew et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases
Colin R. Dormuth et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Diabetes Risk Potentially Underestimated in Youth and Children Receiving Antipsychotics
Katherine Samaras et al.
JAMA PSYCHIATRY (2014)
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
Eliano Pio Navarese et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Statins and risk of treated incident diabetes in a primary care population
Nur Lisa Zaharan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials
Huseyin Naci et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Diabetes Mellitus and Cardiovascular Events in Older Patients With Myocardial Infarction Prescribed Intensive-Dose and Moderate-Dose Statins
Dennis T. Ko et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Statins and Risk of Diabetes An analysis of electronic medical records to evaluate possible bias due to differential survival
Goodarz Danaei et al.
DIABETES CARE (2013)
Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance
Chao Deng
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2013)
Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose
V. Sazonov et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
Wired on sugar: the role of the CNS in the regulation of glucose homeostasis
Bernadette E. Grayson et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk
R. Izzo et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Differential Impact of Statin on New-Onset Diabetes in Different Age Groups: A Population-Based Case-Control Study in Women from an Asian Country
Chih-Wei Chen et al.
PLOS ONE (2013)
Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort et al.
WORLD PSYCHIATRY (2013)
Risk of incident diabetes among patients treated with statins: population based study
Aleesa A. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
A Retrospective Longitudinal Cohort Study of Antihypertensive Drug Use and New-Onset Diabetes in Taiwanese Patients
Ching-Ya Huang et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
Jacqueline Capeau et al.
AIDS (2012)
Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications A Systematic Review and Meta-analysis
Lisa Hartling et al.
ANNALS OF INTERNAL MEDICINE (2012)
Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
Annie L. Culver et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL study
S. Simsek et al.
DIABETIC MEDICINE (2012)
A Double-Blind, Placebo-Controlled, Crossover Trial Comparing the Effects of Amiloride and Hydrochlorothiazide on Glucose Tolerance in Patients With Essential Hypertension
Anna J. Stears et al.
HYPERTENSION (2012)
Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
Kang-Ling Wang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Marc De Hert et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Opposing Effects of β Blockers and Angiotensin-Converting Enzyme Inhibitors on Development of New-Onset Diabetes Mellitus in Patients With Stable Coronary Artery Disease
Orly Vardeny et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?
P. Lee et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
ATORVASTATIN BUT NOT PITAVASTATIN SIGNIFICANTLY INCREASES FASTING PLASMA GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES AND COMBINED DYSLIPIDEMIA
Vladimir Kryzhanovski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin Results From 3 Large Randomized Clinical Trials
David D. Waters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Marc De Hert et al.
WORLD PSYCHIATRY (2011)
Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
William L. Baker et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications
Rhonda M. Cooper-DeHoff et al.
HYPERTENSION (2010)
Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients
Kwang Kon Koh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
Jane Armitage et al.
LANCET (2010)
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Julio D. Duarte et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Antihypertensive Drugs and New-Onset Diabetes: A Retrospective Longitudinal Cohort Study
Gwo-Ping Jong et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Thiazide Effects and Adverse Effects Insights From Molecular Genetics
David H. Ellison et al.
HYPERTENSION (2009)
Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy
Katherine Samaras
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
New onset diabetes during antihypertensive therapy
Michael H. Alderman
AMERICAN JOURNAL OF HYPERTENSION (2008)
First- V. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis
M. Smith et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes
Akira Takaguri et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Incident diabetes in clinical trials of anti hypertensive drugs: a network meta-analysis
William J. Elliott et al.
LANCET (2007)
Thiazide diuretics, potassium, and the development of diabetes - A quantitative review
Alan J. Zillich et al.
HYPERTENSION (2006)
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control
M. Nakata et al.
DIABETOLOGIA (2006)
Thiazide diuretics in the treatment of hypertension: An update
Antonio Salvetti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The impart of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
EL Gillespie et al.
DIABETES CARE (2005)
Adverse prognostic significance of new diabetes in treated hypertensive subjects
P Verdecchia et al.
HYPERTENSION (2004)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care - The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
CD Furberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Adverse effects of antiretroviral therapy
A Carr et al.
LANCET (2000)
Share Paper
